by Bob Yirka , Medical Xpress The recognition of EPCR-LBPA by aPLs promotes autoimmunity. Credit: Science (2021). DOI: 10.1126/science.abc0956 A team of researchers affiliated with multiple institutions in Germany and the U.S. have found a cell-surface target for autoantibodies targeting phospholipids (aPL) that contribute to antiphospholipid syndrome (APS). In their paper published in the journal Science, the group describes how...
